{*Long COVID / Coronavirus Disease (COVID-19)}

Summary

Coming Soon

Symptoms

Coming Soon

Diagnostic Criteria

Under Investigation

Study Classification Criteria

Under Investigation

Diagnostic Tests

Under Investigation

Organized Autoimmunity

(Alternative Autoimmune Disease Classification: FIEM, MIEM or BIEM, or FEM, MEM or BEM)

1. sex predominance (is an autoimmune disease primarily found in genetic Females, Males, or equally in Both?)

   1. Under Investigation

2. Inherited and acquired gene variations that cause increased susceptibility

   1. Human Leukocyte Antigen (HLA) Associations

      1. Under Investigation

   2. Other Gene Variations (mutations)

      1. interleukin 2 receptor subunit alpha (IL2RA), “Patients with severe Coronavirus Disease 2019 (COVID-19), the disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have significantly elevated levels of IL2R in their plasma…Note: This gene has been reviewed for its involvement in coronavirus biology, and is relevant for COVID-19 prognosis.” (National Institutes of Health, 2023)

3. Gene Triggering Environmental Exposures

   1. Infections

      1. Under Investigation

   2. Toxins

   3. Stress

4. Multiple interactive and destructive immune system pathologies

   1. Innate (immediate) immune response

      1. Under Investigation

   2. Adaptive (learned) immune response

      1. Under Investigation

Tissue-Type or Cell-Type Attacked

Under Investigation

Treatment

Under Investigation

Managing Specialist(s)

Under Investigation

Research Authors

Under Investigation

Research Institutions

Under Investigation

Average Time from Symptom Onset to Diagnosis

Under Investigation

Last Updated

April 27, 2023

References

IL2RA interleukin 2 receptor subunit alpha [ Homo sapiens (human) ]. National Institutes of Health, National Library of Medicine, National Center for Biotechnology Information, Gene Database. (2023). Retrieved April 27, 2023 from https://www.ncbi.nlm.nih.gov/gene/3559